Farwell Wildon 4
4 · Dyne Therapeutics, Inc. · Filed Jan 26, 2024
Insider Transaction Report
Form 4
Farwell Wildon
Chief Medical Officer
Transactions
- Sale
Common Stock
2024-01-26$25.00/sh−100$2,500→ 168,996 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 14, 2023.
- [F2]Includes 145,667 unvested RSUs.